Pulmonary Extraintestinal Manifestation of Crohn's Disease Treated Successfully with Adalimumab.
10.4166/kjg.2018.72.3.141
- Author:
Dongyeol SHIN
1
;
Byung Kyu PARK
;
Jeonghun SEO
;
Sun Young WON
;
Mi Kyoung LEE
;
Yong Kook HONG
;
Yong Suk CHO
Author Information
1. Division of Gastroenterology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea. cho6706@hanmail.net
- Publication Type:Case Report
- Keywords:
Crohn disease;
Inflammatory bowel diseases;
Multiple pulmonary nodules;
Extraintestinal manifestation
- MeSH:
Adalimumab*;
Crohn Disease*;
Diagnosis;
Humans;
Inflammatory Bowel Diseases;
Infliximab;
Lung;
Multiple Pulmonary Nodules
- From:The Korean Journal of Gastroenterology
2018;72(3):141-145
- CountryRepublic of Korea
- Language:English
-
Abstract:
Pulmonary extraintestinal manifestation is rare in Crohn's disease and has been reported in only a few cases. Despite the presence of pulmonary abnormalities in a significant proportion of patients with inflammatory bowel disease, there are only few case reports, due to complicated diagnosis and low recognition by clinicians. Currently, treatment guidelines for pulmonary Crohn's disease have not been established. There are some case reports of pulmonary Crohn's disease that achieved remission after infliximab treatment. Clinical and radiological remission of pulmonary extraintestinal involvement in Crohn's disease after adalimumab therapy has not been reported yet. Here, we report one case of lung involvement of Crohn's disease, which shows radiological and clinical remission after adalimumab treatment.
